Charles E Sheedy bought $94k of AURX
owner at Nuo Therapeutics, Inc.. 125,000 shares at an average of $0.75, traded Sep 18, 2024, filed Sep 19, 2024.
Score components
- +12Role10% owner
- +10Trade size$94k at market
- 0Relative to holdingsHoldings up 1.1%
- +8Price context44% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (1 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +13.0%, 3m +155.9%, 6m +115.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-24-029634, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 18, 2024 | POpen-market purchase Common Stock | +125,000 | $0.75 | $94k | 11,437,500 | Sep 19, 2024 |
Related signals
Other insiders at Nuo Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 28Weak | AURXbuy Nuo Therapeutics, Inc. | David Emerson Jorden CEO/CFO | $9,539 8,773 shares | +0% | |
| 39Weak | AURXsell Nuo Therapeutics, Inc. | David Emerson Jorden CEO/CFO | $300k 200,000 shares | -9% | |
| 19Weak | AURXbuy Nuo Therapeutics, Inc. | Charles E Sheedy owner | $200k 133,333 shares | +1% | |
| 18Weak | AURXbuy Nuo Therapeutics, Inc. | Charles E Sheedy owner | $75k 100,000 shares | +1% | |
| 23Weak | AURXbuy Nuo Therapeutics, Inc. | Charles E Sheedy owner | $75k 150,000 shares | +1% | |
| 38Weak | AURXsell Nuo Therapeutics, Inc. | David Emerson Jorden CEO/CFO | $244k 162,500 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.